Article Figures & Data
Figures
- FIGURE 1.
Two images from same patient obtained 3 wk apart: planar 111In-octreotide scan (A) and 68Ga-DOTATATE PET scan (B). Lesions within liver are more easily identified on higher resolution of PET scan than on planar octreotide scan.
- FIGURE 2.
Abnormal uptake (arrows) of 18F-fluciclovine in metastatic lymph node in right pelvis on PET images obtained 5–16 min after injection (A), 17–28 min after injection (B), and 29–40 min after injection (C). Uptake increases in urinary bladder over time.
- FIGURE 3.
Abnormal uptake of 11C-choline in right ilium and pubis on PET (left panels in A and B) and PET/CT (right panels in A and B) images obtained before (A) and after (B) treatment.
- FIGURE 4.
18F-FDG (A) and 11C-acetate (B) uptake (arrows) on PET images of patient with metastatic prostate cancer.
- FIGURE 5.
18F-fluciclovine (A) and 68Ga-PSMA (B) uptake on PET images of patient with metastatic prostate cancer. Faint uptake of 18F-fluciclovine is seen in left prostate gland (blue arrow), and uptake of 68Ga-PSMA is seen in prostate gland and extrapelvic lymph nodes (yellow arrows).
- FIGURE 6.
Transaxial PET slices demonstrating 18F-florbetapir–negative scan (left) and amyloid-positive scan (right).
- FIGURE 7.
Transaxial PET slices demonstrating 18F-flutametamol–negative scan (left) and amyloid-positive scan (right).
- FIGURE 8.
Sagittal and transaxial PET slices demonstrating 18F-florbetaben–negative scan (left) and 18F-florbetaben–positive scan (right). SUVR = SUV ratio.
- FIGURE 9.
Short-axis (top), vertical long-axis (middle), and horizontal long-axis (bottom) PET myocardial perfusion images obtained using 18F-flurpiridaz during various cardiac and respiratory gating. Cardiac MF = cardiac motion frozen, no respiratory gating; ORG = optimal respiratory gating.
